February 10, 2021
The TARC Core Center for Clinical Research (CCCR) Announces RFA for Pilot & Feasibility Studies
The program provides seed money of up to $25K for 1 year to initiate new and innovative projects.
February 10, 2021
The program provides seed money of up to $25K for 1 year to initiate new and innovative projects.
January 28, 2021
The UNC Integrated Translational Oncology Program (iTOP) training program focuses on training clinicians, basic scientists, and MD-PhD candidates in clinical/translational disease-based research.
January 13, 2021
HERO-TOGETHER, a new research study, will gain insights on how COVID-19 vaccination can help keep communities healthy and free of the virus.
October 28, 2020
Janeth Pearl, residente de Cary, explica por qué participa en el ensayo clínico de la vacuna COVID-19.
October 6, 2020
Craig Cameron, PhD, Chair of the Department of Microbiology and Immunology, discusses his reasons for participating in the Moderna vaccine phase III clinical trial at UNC.
August 6, 2020
The NC TraCS Inclusive Science Program (ISP) has recently launched the Rural Health Research Toolkit, a resource for researchers designing and conducting research focusing on rural communities.
July 16, 2020
Nicholas Shaheen, MD, MPH, a world-renowned gastroenterologist and epidemiologist, will take up the mantle held by longtime TraCS leader Tim Carey, MD, PhD.
May 27, 2020
The National Cancer Institute awarded UNC Lineberger researcher Nancy E. Thomas, MD, PhD and collaborators a five-year, $4.6-million grant to study the identification of lethal melanomas at the time of diagnosis.
May 6, 2020
An international team of researchers co-led by UNC School of Medicine’s Karen Mohlke, PhD, conducted the largest-ever genome-wide study of people from across East Asia to uncover the genetic roots of type 2 diabetes.
June 26, 2019
In an effort to bolster the engagement of junior clinician scientists in research, the School of Medicine is rolling out a new incentive to support research activities of clinician scientists in their departments. To apply for funding, clinical departments should submit the names and degrees of current K awardees in their departments by July 12, 2019.
March 20, 2019
ZULRESSO, developed by Sage Therapeutics, is the first and only treatment specifically indicated to treat postpartum depression in women. UNC School of Medicine’s Samantha Meltzer-Brody, MD, MPH, was the principal investigator for three clinical trials showing rapid-reduction in depressive symptoms, and says the approval marks a major step forward in women’s healthcare.
November 19, 2018
The treatment, AR101 from Aimmune Therapeutics, was based on research conducted in the lab of Wesley Burks, MD. It significantly increased the amount of peanut protein tolerated. UNC’s Edwin Kim, MD, MS, was PI at the UNC site of this international trial.